Key facts
- TruNativ, a clean-label nutrition brand, has secured $30 million in funding.
- The funding round was led by healthcare-focused investor OrbiMed Advisors LLC.
- The capital will be used to boost distribution, expand product offerings, and establish a new R&D center.
- The company also plans to grow its B2B2C ingredients business.
- TruNativ reported Rs 130 crore in revenue for FY26 and expects Rs 200 crore for the current financial year.
Clean-label nutrition brand TruNativ has successfully closed a $30 million funding round, with OrbiMed Advisors LLC leading the investment. The deal includes both primary capital infusion and the sale of secondary shares by some of the company's early investors.
Founded in 2019 by Pranav and Mamta Malhotra, TruNativ operates in categories such as sugar alternatives, protein, gut health, and general wellness. CEO Pranav Malhotra stated that the company aims to integrate nutrition into daily life, addressing the post-pandemic increase in consumer awareness about nutritional needs.
The newly acquired capital will be strategically deployed to scale distribution networks, broaden the existing product portfolio, and establish a new research and development center in Mumbai. Additionally, the funds will bolster TruNativ's B2B2C ingredients business, which supplies consumer brands across India.
Dr. Sunny Sharma, senior managing director at OrbiMed Asia, expressed shared enthusiasm for TruNativ's mission to improve nutrition and health outcomes nationwide. TruNativ reported revenues of Rs 130 crore in the fiscal year 2026 and is on track to achieve Rs 200 crore in the ongoing financial year. The company competes with other players in the wellness sector, including OZiva, Wellbeing Nutrition, and Plix.